Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (1): 14-17.DOI: 10.3969/j.issn.1673-8640.2017.01.004

• Orginal Article • Previous Articles     Next Articles

Percentages of peripheral blood CD4+CD25+CD127low T cells before and after the treatment of paternal lymphocyte induced immunization in patients with unexplained recurrent spontaneous abortion

LI Cui, SHI Youhao, WU Jiangnan, YING Chunmei   

  1. Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200011,China
  • Received:2016-03-31 Online:2017-01-20 Published:2017-02-10

Abstract:

Objective To investigate the expression of peripheral blood CD4+CD25+CD1271ow T cells in regulatory T cells (Treg) of patients with unexplained recurrent spontaneous abortion(URSA),to analyze the percentages before and after the treatment of paternal lymphocyte induced immunization,and to evaluate its probability as a diagnosis indicator for abortion. Methods By flow cytometry,the percentages of peripheral blood CD4+CD25+CD1271ow T cells were determined in 73 patients with URSA before the treatment,76 healthy women with early pregnancy and 69 healthy women without pregnancy. A total of 51 patients with URSA underwent the treatment of paternal lymphocyte induced immunization for 2-3 treatment courses. Their percentages were determined as well. Results Before the treatment,the percentage of CD4+CD25+CD1271ow T cells in URSA group (2.73%±0.56%) was lower than those in healthy pregnancy and non-pregnancy groups(4.36%±1.07% and 2.93%±0.60%)(P<0.05). After the treatment,the percentage(3.72%±1.15%)was higher than that before the treatment(P<0.05). The pregnancy outcome of 42 patients after the treatment was good,while the treatment for the other 9 patients failed. Conclusions The percentage of peripheral blood CD4+CD25+CD1271ow T cells in URSA patients is lower than those in healthy pregnant and non-pregnant women,which can be as a diagnosis indicator for URSA,and it can be improved by the treatment of paternal lymphocyte induced immunization.

Key words: CD4+CD25+CD1271ow T cells, Unexplained recurrent spontaneous abortion, Paternal lymphocyte induced immunization treatment

CLC Number: